• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

MIRA Pharmaceuticals, Inc. - Common Stock (NQ: MIRA )

2.200 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MIRA Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 Next >
S&P 500 Gains 1%; MIRA Pharmaceuticals Shares Spike Higher
July 22, 2024
Via Benzinga
Topics Stocks
Exposures US Equities
Why CrowdStrike Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
July 22, 2024
Via Benzinga
Why Is MIRA Pharmaceuticals (MIRA) Stock Up 318% Today?
July 22, 2024
MIRA Pharmaceuticals stock is up on Monday after the company posted results from a pre-clinical trial of its novel oral ketamine analog. 
Via InvestorPlace
MIRA Pharmaceuticals Reveals Preclinical Success: Ketamir-2 Optimized for Brain Delivery, Avoiding Ketamine's Drug Resistance
July 22, 2024
Via ACCESSWIRE
Mira Pharmaceuticals Announces Promising Results for MIRA-55 in Multiple Preclinical Tests Compared to THC
July 15, 2024
Via ACCESSWIRE
Dow Edges Lower; Verizon Shares Fall After Q2 Results
July 22, 2024
Via Benzinga
Topics Stocks
Exposures US Equities
Nano-Cap MIRA Pharmaceuticals' Oral Ketamine Analog Shows Potential In Neuropsychiatric Disorders
July 22, 2024
MIRA Pharmaceuticals reveals preclinical data for its novel oral ketamine analog, Ketamir-2, targeting neurological and neuropsychiatric disorders. With superior oral absorption and efficacy, Ketamir-2... 
Via Benzinga
Nasdaq Gains 1%; Chicago Fed National Activity Falls In June
July 22, 2024
Via Benzinga
Topics Economy
Exposures Interest Rates
Why SolarEdge Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
July 15, 2024
Via Benzinga
Why Mira Pharmaceuticals Stock Is Moving Higher Monday
July 15, 2024
MIRA Pharmaceuticals said testing confirmed MIRA's preliminary beliefs regarding a new potential treatment for neurological and neuropsychiatric disorders. 
Via Benzinga
Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Falls In July
July 15, 2024
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Thursday's Intraday Session
May 30, 2024
Via Benzinga
Dow Falls Over 150 Points; Sohu Posts Q1 Loss
May 20, 2024
Via Benzinga
Topics Stocks
Exposures US Equities
Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session
May 20, 2024
Via Benzinga
MIRA Stock Earnings: Mira Pharmaceuticals Misses EPS for Q1 2024
May 13, 2024
MIRA stock results show that Mira Pharmaceuticals missed analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
April 02, 2024
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 02, 2024
Via Benzinga
MIRA Stock Earnings: Mira Pharmaceuticals Beats EPS for Q4 2023
April 01, 2024
MIRA stock results show that Mira Pharmaceuticals beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
Why MariaDB Shares Are Trading Higher By Around 100%; Here Are 20 Stocks Moving Premarket
March 27, 2024
Shares of MariaDB plc (NYSE: MRDB) rose sharply in today’s pre-market trading after Progress Software (NASDAQ: PRGS) announced that it is possibly considering an offer for the company. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
March 27, 2024
It's time to dive into the biggest pre-market stock movers for Wednesday morning as we check out all of the hottest news! 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
March 26, 2024
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
March 14, 2024
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
March 13, 2024
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
March 11, 2024
Pre-market stock movers are a great way to start the week as we check out all of the biggest trades happening on Monday morning! 
Via InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
March 08, 2024
Via Benzinga
Medical Marijuana-Focused Mira Pharmaceuticals Stock Surges After Neuropsychiatric Disorders Update - Here's Why
March 08, 2024
MIRA Pharmaceuticals' revelation on MIRA1a. Uncover MIRA-55, a potent oral marijuana drug candidate for anxiety and cognitive decline. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
12 Health Care Stocks Moving In Friday's Intraday Session
March 08, 2024
Via Benzinga
Why Marvell Technology Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
March 08, 2024
Shares of Marvell Technology, Inc. (NASDAQ: MRVL) fell sharply during Friday’s session after the company reported fourth-quarter financial results and issued weak Q1 guidance. 
Via Benzinga
ASTR Stock Alert: Astra Space Is Going Private
March 08, 2024
Astra Space stock is in the news Friday as ASTR investors react to news that the company is being taken private in Q2 2024. 
Via InvestorPlace
Why Is AerSale (ASLE) Stock Down 18% Today?
March 08, 2024
AerSale stock is down on Friday as investors in ASLE react to misses in the aftermarket commercial aircraft seller's Q4 2024 earnings report. 
Via InvestorPlace
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap